Ondine Biomedical, Inc.'s total assets for Q4 2024 were C$12.82M, an increase of 218.56% from the previous quarter. GB:OBI total liabilities were C$5.95M for the fiscal quarter, a 48.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.